1 Min Read
Feb 20 (Reuters) - Claris Lifesciences Ltd:
* Gets members' nod for sale and transfer of injectable business of co by way of sale of subsidiary companies Source text: bit.ly/2kD0uPT Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.